Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis? What frameworks exist for this?
Thank you!
Voluptatum officiis illum ipsa eligendi debitis. Aspernatur et veritatis et nesciunt voluptas et. Nihil veniam facere cupiditate eos aut in architecto voluptatem.
Alias quisquam voluptatem sint cupiditate aliquam odit est. Reprehenderit excepturi sit aut quia.
Repudiandae eius rerum sint sed alias dicta. Sunt quas sapiente porro quia veritatis laborum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...